Creative Planning Amgen Inc Put Options Transaction History

Creative Planning

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $188,209 - $227,192	700 New	700 $199,000
Q4 2020 Jan 29, 2021	SELL	$216.38 - $257.67 $64,914 - $77,301	-300 Reduced 30.0%	700 $2,000
Q3 2020 Nov 05, 2020	BUY	$234.65 - $260.95 $70,395 - $78,285	300 Added 42.86%	1,000 $0
Q2 2019 Jul 26, 2019	BUY	$166.7 - $195.41 $116,689 - $136,787	700 New	700 $1,000

3,119

407M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.